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ABSTRACT
Background
Understanding the three-dimensional (3D) volumetric
relationship between imaging and functional or his-
topathologic heterogeneity of tumours is a key concept
in the development of image-guided radiotherapy. Our
aim was to develop a methodologic framework to en-
able the reconstruction of resected lung specimens
containing non-small-cell lung cancer (NSCLC), to reg-
ister the result in 3D with diagnostic imaging, and to
import the reconstruction into a radiation treatment
planning system.
Methods and Results
We recruited 12 patients for an investigation of radiol-
ogy–pathology correlation (RPC) in NSCLC. Before re-
section, imaging by positron emission tomography (PET)
or computed tomography (CT) was obtained. Resected
specimens were formalin-fixed for 1–24 hours before
sectioning at 3-mm to 10-mm intervals. To try to re-
tain the original shape, we embedded the specimens in
agar before sectioning. Consecutive sections were laid
out for photography and manually adjusted to maintain
shape. Following embedding, the tissue blocks under-
went whole-mount sectioning (4-μm sections) and
staining with hematoxylin and eosin. Large histopa-
thology slides were used to whole-mount entire sec-
tions for digitization. The correct sequence was
maintained to assist in subsequent reconstruction.
Using Photoshop (Adobe Systems Incorporated,
San Jose, CA, U.S.A.), contours were placed on the
photographic images to represent the external borders
of the section and the extent of macroscopic disease.
Sections were stacked in sequence and manually ori-
ented in Photoshop. The macroscopic tumour contours
were then transferred to MATLAB (The Mathworks,
Natick, MA, U.S.A.) and stacked, producing 3D sur-
face renderings of the resected specimen and embed-
ded gross tumour. To evaluate the microscopic extent
of disease, customized “tile-based” and commercial
confocal panoramic laser scanning (TISSUEscope:
Biomedical Photometrics, Waterloo, ON) systems were
used to generate digital images of whole-mount his-
topathology sections. Using the digital whole-mount
images and imaging software, we contoured the gross
and microscopic extent of disease.
Two methods of registering pathology and imaging
were used. First, selected PET and CT images were
transferred into Photoshop, where they were contoured,
stacked, and reconstructed. After importing the pathol-
ogy and the imaging contours to MATLAB, the con-
tours were reconstructed, manually rotated, and rigidly
registered. In the second method, MATLAB tumour
renderings were exported to a software platform for
manual registration with the original PET and CT im-
ages in multiple planes. Data from this software plat-
form were then exported to the Pinnacle radiation
treatment planning system in DICOM (Digital Imaging
and Communications in Medicine) format.
Conclusions
There is no one definitive method for 3D volumetric
RPC in NSCLC. An innovative approach to the 3D re-
construction of resected NSCLC specimens incorporates
agar embedding of the specimen and whole-mount dig-
ital histopathology. The reconstructions can be rigidly
and manually registered to imaging modalities such as
CT and PET and exported to a radiation treatment plan-
ning system.DAHELE et al.
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1. INTRODUCTION
Lung cancer is the leading cause of cancer death in
Canada, and it is associated with one of the lowest
survival rates of all cancers 1. Radiotherapy is fre-
quently used in the treatment of lung cancer 2. Radio-
therapy is a paradigm for image-guided therapies that
include surgical and interventional radiology tech-
niques. Image-guided therapies have in common a need
to understand the relationship between what is visual-
ized on imaging [for example, computed tomography
(CT)] and the “true” pathologic extent of gross and
microscopic disease. This need was the motivation for
the study described here.
In the case of radiotherapy, the accurate delinea-
tion of the gross tumour volume (GTV) is a critical step
in treatment planning. However, there are currently
several weak links in this process. The significant in-
ter-observer variation that occurs in CT-based GTV 3 is
only partially reduced by the integration of 18F
fluorodeoxyglucose (FDG) positron emission tomogra-
phy (PET) imaging 4. Also, it is unclear how large a
margin should be added to the GTV to account for mi-
croscopic tumour extension to generate the clinical tar-
get volume. Therefore, in practice, a uniform 5-mm to
10-mm margin is often added around the GTV, on the
assumption that the CT-based GTV is inadequate. Such
shortcomings provide a rationale for studies to investi-
gate whether what is seen on CT or PET imaging accu-
rately reflects the underlying pathologic extent of
disease in NSCLC and how best to view and segment
CT and PET images to reflect that pathology.
Radiology–pathology correlation (RPC) is one
investigational approach to this problem (Figure 1).
Several authors have described some form of RPC in
NSCLC 5–10, using techniques that vary in complexity.
Giraud et al. 5 used a two-dimensional methodology.
These authors examined 354 pathology slides from 70
lobectomy or pneumonectomy specimens that had been
insufflated with 10% formalin. They identified the
macroscopic extent of disease by naked eye and found
that their observations correlated well (p < 0.001) with
tumour dimension on CT scans at the “optimal win-
dow/level setting” (which was undefined). They further
determined that margins of 8 mm for adenocarcinomas
and 6 mm for squamous carcinomas were needed to
account for microscopic extension with 95% probabil-
ity. They recognized that their calculations were af-
fected by the degree of insufflation of the specimen.
The recently reported pilot study by Stroom et al. 10 used
more advanced methodology to begin to account for ex
vivo changes in tissue dimensions and geometry.
Such studies make it apparent that robust RPC in
the lung is a difficult undertaking. However, few papers
speak directly to the challenges that are encountered
in this work. In this qualitative report of our initial ex-
perience with developing a three-dimensional (3D)
methodology for PET or CT RPC in NSCLC, we discuss
some of these challenges, report our methodology, and
highlight future areas of research.
Our aim was to develop a methodology that would
achieve these ends:
￿ Fix the resected specimen in a shape and size re-
flective of the in vivo state
￿ Maintain the spatial orientation of the specimen
and sections throughout the process
￿ Enable the assessment of macroscopic and micro-
scopic disease
￿ Permit a 3D reconstruction of resected specimens
￿ Allow for specimen contours to be registered with
PET or CT images and to be imported into a com-
mercial radiation treatment planning system
2. METHODS AND RESULTS
With institutional research ethics board approval, we
recruited 12 patients to a study designed to investigate
RPC in NSCLC (Table I). All patients were scheduled to
undergo surgical resection of NSCLC, with or without
induction chemoradiation. Because the optimum means
of fixing pathology tissue for RPC has yet to be deter-
mined and was to be investigated, it was stipulated
that whatever tissue would ordinarily be taken for rou-
tine clinical pathology reporting would continue to be
acquired so as not to compromise patient management.
This necessary requirement, combined with the small
size of most of the tumours (7 were 3 cm or smaller),
reduced the amount of tissue that was available for
study purposes.
Throughout the course of the study, each specimen
was processed so as to try to improve on the preceding
effort. The resulting methodology is described.
FIGURE 1   Complete pathologic response following induction
chemotherapy and chemoradiation. A fibrotic rim surrounds a
necrotic core. The preoperative 18F fluorodeoxyglucose PET scan
demonstrates corresponding areas of rim enhancement and a
photopenic centre (arrows).CORRELATION OF PET–CT AND WHOLE-MOUNT HISTOPATHOLOGY
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2.1 Preoperative Imaging and Handling of the
Resected Specimen
All patients underwent combined FDG  PET or CT
imaging before tumour resection. These operative tech-
niques were used:
￿ Wedge resection and segmentectomy (n = 3)
￿ Lobectomy (n = 8)
￿ Pneumonectomy (n = 1)
One specimen incorporated a chest wall resection
and was unsuitable for further analysis. The remaining
specimens (11 of 12) were insufflated with 10% for-
malin by endobronchial or transparietal injection, or
both. Injection ceased when the specimen was satu-
rated and formalin was being exuded across the pleura.
Where necessary, surfaces were inked to aid orienta-
tion. At that point, the specimen was photographed with
an accompanying centimetre scale. It was then im-
mersed in formalin for a time that varied from 1 to 24
hours for initial fixation.
2.2 Sectioning and Processing the Specimen
After initial fixation, the specimens were sectioned at
intervals of approximately 3–10 mm. The choice of
location and the direction of the first cut was made on
clinical grounds, and all subsequent sections were par-
allel to the first. A very sharp blade is required to mini-
mize shear and tearing when cutting through different
tissues simultaneously (for example, lung parenchyma
and cartilage). Various methods of sectioning were tried,
including freehand knife, customized sectioning box
(metal box designed to contain the specimen during
cutting), and electric rotary cutter. Freehand cutting was
the least reliable, and in general, the combination of
the electric rotary cutter and agar embedding (discussed
next) provided the most consistent sections.
The duration of initial fixation made little differ-
ence to the rigidity of the specimen. Even prolonged
fixation was insufficient to ensure alignment of the
successive sections. In addition, when the inflated gross
specimen was cut, the retained formalin ran out, caus-
ing specimens to deflate to a greater or lesser extent,
contributing to the variability of sections and reducing
the likelihood that radiology and pathology would cor-
relate without some form of image registration and
deformation. These particular techniques were not used
in this study, which focused on the physical presenta-
tion of the specimen.
To try to retain shape, some of the specimens were
embedded in agar before sectioning. This technique
surrounds the specimen with a 3.5% agar mixture, ini-
tially at 55°C before cooling 11. Before the agar was
used, it was first applied to regions of lung tissue re-
mote from the tumour. An experienced lung patholo-
gist then examined tissue sections and determined that
no significant microscopic tissue damage had occurred
as a result of the temperature used in the process. How-
ever, despite preparing the pleural surface with alco-
hol, the lung did not reliably stick to the agar. As a
result, in cases in which little collapse of the specimen
occurred on sectioning, the agar helped to maintain
conformation of the sections (Figure 2). But where the
specimen collapsed significantly or where shearing on
cutting occurred, the agar made less difference.
The agar method has benefits, but additional work
is needed to refine the physical preparation of lung
specimens in RPC.
The naked-eye extent of macroscopic disease was
measured at sectioning by an experienced lung patholo-
gist. Consecutive sections were laid out for photogra-
phy and were manually adjusted to maintain shape.
Excess surface formalin was removed, and the sec-
tions were digitally photographed with an accompany-
ing scale or centimetre grid (Figure 3). Where possible,
each specimen was aligned with the central axis of the
TABLE I Characteristics of the study population
Patient Operation Histology Maximum gross tumour dimension
1 RLL Squamous 10 cm
2 RUL + chest wall resection a Adenocarcinoma 8 cm
3 RUL Adenocarcinoma 3.2 cm
4 Segmentectomy Adenocarcinoma 3 cm
5 Segmentectomy Squamous 2.9 cm
6 RUL BAC/adenocarcinoma 2.5 cm
7 LUL Adenocarcinoma 2.1 cm
8 RUL Adenocarcinoma 2 cm
9 Wedge resection Squamous 1.6 cm
10 LLL Adenocarcinoma 1.2 cm
11 RUL NSC carcinoma No residual tumour b (Figure 1)
12 Pneumonectomy Large-cell carcinoma No residual tumour b
a   Not suitable for study because of attached chest wall.
b   Complete pathologic response following chemoradiation.
RLL = right lower lobectomy; RUL = right upper lobectomy; BAC = bronchoalveolar carcinoma; LUL = left upper lobectomy; LLL = left lower
lobectomy; NSC = non-small-cell.DAHELE et al.
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camera at a fixed distance from the lens and with the
scale at the same height as the uppermost surface of
the section.
After the necessary removal of samples for clini-
cal reporting, the remaining sections from a total of 4
specimens underwent tissue processing and paraffin
embedding (this step was governed by the availability
and suitability of remaining tissue, which were influ-
enced by such factors as tumour size and location).
Following embedding, the tissue blocks underwent
whole-mount sectioning (4 μm sections) and staining
with hematoxylin and eosin. Large histopathology slides
(for example, 5 × 3 inches) were used to whole-mount
entire sections in preparation for digitization (Figure 4).
The correct sequence was maintained, and the loca-
tion of any slices that had been removed was noted to
assist in the subsequent volumetric reconstruction.
2.3 Identifying and Reconstructing Gross and
Microscopic Disease
Using Photoshop (Adobe Systems Incorporated, San
Jose, CA, U.S.A.), contours were placed on the pho-
tographic images to represent the external border of
the section, and the extent of macroscopic disease
(Figure 5). These sections were stacked in sequence
and manually oriented in Photoshop using natural con-
tours and intrinsic fiducial landmarks (for example,
bronchi). To maintain the clinical integrity of the
specimen, implanted fiducial markers were not used
in the present study, although it is likely that such
markers would have improved the registration of sec-
tions. Such markers would also have been of use in
evaluating image deformation.
The macroscopic tumour contours were then trans-
ferred to MATLAB, where they were stacked at an
appropriate distance apart (compensating for missing
slices where necessary). The stacking resulted in 3D
surface renderings of the resected specimen and em-
bedded gross tumour (Figure 6).
To evaluate the microscopic extent of disease, cus-
tomized “tile-based” 12 and commercial confocal pano-
ramic laser scanning [TISSUEscope (Biomedical
Photometrics, Waterloo, ON)] systems were used to
FIGURE 2  The utility of embedding specimens in agar after initial
formalin fixation was studied. In selected cases, it helped to maintain
the conformation of sections.
FIGURE 3   The resected specimen is sectioned after insufflation with
10% formalin and is photographed with an overlying grid (pale
tumour is seen on the right of each section).
FIGURE 4   After additional processing, whole-mount sections 4 μm in
thickness are cut and stained with hematoxylin and eosin.CORRELATION OF PET–CT AND WHOLE-MOUNT HISTOPATHOLOGY
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generate digital images of complete whole-mount his-
topathology sections (Figure 7). We were able to gen-
erate at least 1 good quality whole-mount section in 4
patients. Digital whole-mount pathology images of
varying spatial resolution—1, 2, 5, and 10 μm—were
evaluated by experienced lung pathologists to deter-
mine the resolution adequate for assessing microscopic
disease. The expert consensus was to use a resolution
of 2 μm. Using the digital whole-mount images and
imaging software, a lung pathologist contoured both
the gross and the microscopic extent of disease. Had
sufficient sequential slides been available to be proc-
essed in this fashion, the slides could then have been
reconstructed to provide a 3D histopathologic repre-
sentation of the tumour.
2.4 Registering Pathology and Imaging Data and
Exporting Information to the Radiation
Treatment Planning System
Two methods of registering pathology and imaging were
used. In the first, selected PET or CT images were trans-
ferred into Photoshop (ensuring correct scaling of the
images). These images were then contoured, stacked,
and reconstructed as described earlier. A range of win-
dow and level settings and segmentation approaches
can be used to generate the PET or CT tumour bounda-
ries. After the pathology and imaging contours are im-
ported to MATLAB, they can be reconstructed,
manually rotated, and rigidly registered (Figure 8). In
the second method, MATLAB tumour renderings were
exported to a software platform that permitted manual
registration with the original PET or CT images in the
axial, coronal, and sagittal planes (Figure 9).
Either of the foregoing registration methods allows
for pathology-based and imaging-based volumes (at
various window and level and segmentation thresholds)
to be measured. Differences in the volumes give some
idea of relative changes in the tissues between the in
vivo and ex vivo states.
FIGURE 5  The gross section is photographed, and the lung
parenchyma, visible tumour, and any intrinsic fiducial landmarks
are contoured using Photoshop (Adobe Systems Incorporated, San
Jose, CA, U.S.A.).
FIGURE 6   The contours from digital photographs are transferred
into MATLAB (The Mathworks, Natick, MA, U.S.A.) and expanded
to generate a three-dimensional rendering of the resected specimen.
A contiguous outer surface relies on conformation of the sections
being retained between sectioning and laying out the specimen. No
extrapolation was used between sections. Green = reconstructed
tumour; red and pink = surrounding lung parenchyma.
FIGURE 7  Digitised histopathology is generated from the whole-mount
sections. The resolution can be varied. We determined that 2 μm was
adequate for identifying microscopic disease.
1μm 2μm
5μm 10μmDAHELE et al.
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Data from this software platform were then ex-
ported to the Pinnacle3 (Philips Medical Systems,
Cleveland, OH, U.S.A.) radiation treatment planning
system in DICOM (Digital Imaging and Communica-
tions in Medicine) format. This is one method by which
pathology information can be integrated into the study
of radiation treatment planning.
2.5 Image Registration and Deformation and
Overall Accuracy of the Method
A change occurs in the 3D conformation of tissues
between the in vivo and ex vivo states. Reasons for
this change include the physical properties of lung tis-
sue, with its tendency to collapse, which can lead to
the systematic propagation of conformational changes
throughout the study process and specimen processing
(Figure 10). It is difficult to compensate for these
changes, and physical efforts such as those discussed
here are likely to benefit from the addition of sophisti-
cated image registration and deformation technologies.
In considering the overall accuracy of any method
for RPC in NSCLC, the difference between what is of-
ten added empirically for microscopic extension in ra-
diation treatment planning and what was actually
demonstrated by Giraud et al. is noted typically to be
less than 5 mm. Therefore, to generate clinically use-
ful information, an RPC methodology arguably needs
to be accurate to 1–2 mm. Our experience, and the
reported literature, indicates many possible sources of
(cumulative) measurement error that have not yet been
accurately quantified.
3. DISCUSSION AND CONCLUSIONS
Radiology–pathology correlation in lung is challeng-
ing. It requires a range of expertise and logistics coor-
dination and must not compromise clinical reporting.
FIGURE 8  Rigid (manual) registration in three dimensions of the
maximum projections on computed tomography (CT, orange) and
gross tumour as identified on digital photograph (blue).
FIGURE 9  Manual registration in three planes between tumour (blue
contour) reconstructed using digital photographs [Photoshop (Adobe
Systems Incorporated, San Jose, CA, U.S.A.) and MATLAB (The
Mathworks, Natick, MA, U.S.A.)] and a fused PET–CT image.
No single definitive method has been established for
3D volumetric RPC in NSCLC. The present report de-
scribes an innovative approach to the 3D reconstruc-
tion of resected NSCLC specimens. The methodology
incorporates several distinguishing features, including
Coronal
Transaxial
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agar embedding of the specimen and whole-mount dig-
ital histopathology. As described, the reconstructions
can be rigidly and manually registered (with good ap-
proximation) to imaging modalities such as CT and PET
and then exported to a radiation treatment planning sys-
tem. The methodologic principles are expected to be
transferable to other tumour sites 13 and to support a
range of investigative possibilities 14. With the addi-
tion of more precise techniques for image registration
and deformation 15, the overall accuracy of the method
should be improved, enabling the acquisition of quanti-
tative information. To develop robust RPC techniques,
factors such as the timing between imaging and sur-
gery, and the use of respiratory-correlated PET and CT
imaging will become relevant. In conclusion, there-
fore, we have developed a framework for RPC (Ap-
pendix A) and identified discrete areas that would
benefit from further research and refinement.
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APPENDIX A
Development of a framework for three-dimensional
radiology–pathology correlation (RPC)
1. Preoperative positron emission tomography (PET)
or computed tomography (CT) imaging
2. Surgical resection
3. Specimen insufflation with formalin
4. Specimen embedding in agar
5. Specimen sectioning and gross tumour measurement
6. Digital photograph of sections
7. Digital photograph-based tumour reconstruction
and RPC:
￿ Transfer digital images of sections to Photoshop
(Adobe Systems Incorporated, San Jose, CA,
U.S.A.).
￿ Contour gross tumour and specimen edges, as
well as any internal fiducial markers (for exam-
ple, bronchi).
￿ Perform rigid manual registration and stacking
of the contours in Photoshop.
￿ Export the stacked contours to MATLAB (The
Mathworks, Natick, MA, U.S.A.), and recon-
struct the tumour and lung specimen.
￿ Repeat the foregoing four steps with sequential
cross-sectional images of the tumour.
￿ Manually register the reconstructed pathology and
radiology in MATLAB.
￿ Alternatively, export the pathology reconstruc-
tion from MATLAB to another platform that al-
lows for registration of reconstructed pathology
with diagnostic PET or CT images in three di-
mensions, then export data from that platform to
the radiation treatment planning system.
8. Histopathology-based tumour reconstruction:
￿ Process pathology sections, stain with
hematoxylin and eosin, and generate 4 μm whole-
mount sections.
￿ Digitize pathology using tiling-based system or
confocal laser scanning.
￿ Import digital images into a software platform
for contouring of gross and microscopic tumour
at 2 µm resolution.
￿ Reconstruct tumour and specimen using the con-
tours created in the immediately preceding step.
￿ Register with radiology as described for photo-
graph-based reconstruction.